Shingo Inaguma

2.0k total citations
65 papers, 1.3k citations indexed

About

Shingo Inaguma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Shingo Inaguma has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Shingo Inaguma's work include Prostate Cancer Treatment and Research (9 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Shingo Inaguma is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Shingo Inaguma collaborates with scholars based in Japan, United States and Poland. Shingo Inaguma's co-authors include Hiroshi Ikeda, Kenji Kasai, Jerzy Lasota, Markku Miettinen, Satoru Takahashi, Zengfeng Wang, Tomoyuki Shirai, Shugo Suzuki, Hideaki Ito and Anna Felisiak-Gołąbek and has published in prestigious journals such as Cancer Research, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Shingo Inaguma

61 papers receiving 1.3k citations

Peers

Shingo Inaguma
Joo Heon Kim South Korea
Yun‐Bi Ni Hong Kong
Thea Kalebic United States
Kyoung Min Kim South Korea
Jens C. Hahne United Kingdom
Shingo Inaguma
Citations per year, relative to Shingo Inaguma Shingo Inaguma (= 1×) peers Sachin Gopalkrishna Pai

Countries citing papers authored by Shingo Inaguma

Since Specialization
Citations

This map shows the geographic impact of Shingo Inaguma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Inaguma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Inaguma more than expected).

Fields of papers citing papers by Shingo Inaguma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Inaguma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Inaguma. The network helps show where Shingo Inaguma may publish in the future.

Co-authorship network of co-authors of Shingo Inaguma

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Inaguma. A scholar is included among the top collaborators of Shingo Inaguma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Inaguma. Shingo Inaguma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwata, Takashi, et al.. (2025). Amyloid β-related Angiitis Presenting with Subarachnoid Hemorrhage Diagnosed by Brain Biopsy: A Case Report. NMC Case Report Journal. 12(0). 97–101.
2.
Kato, Hiroyuki, Aya Naiki‐Ito, Shingo Inaguma, et al.. (2024). The role of DPYD and the effects of DPYD suppressor luteolin combined with 5‐FU in pancreatic cancer. Cancer Medicine. 13(16). e70124–e70124. 4 indexed citations
3.
Komura, Masayuki, Chengbo Wang, Kazuhiro Nagao, et al.. (2023). Stromal POSTN Enhances Motility of Both Cancer and Stromal Cells and Predicts Poor Survival in Colorectal Cancer. Cancers. 15(3). 606–606. 13 indexed citations
4.
Naiki, Taku, Aya Naiki‐Ito, Taiki Kato, et al.. (2023). Successful treatment with enfortumab–vedotin of metastatic signet ring cell cancer expressing nectin‐4 and originating from the bladder. IJU Case Reports. 7(2). 110–114. 4 indexed citations
5.
Kachi, Kenta, Hiroyuki Kato, Aya Naiki‐Ito, et al.. (2021). Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation. International Journal of Molecular Sciences. 22(14). 7444–7444. 5 indexed citations
6.
Inoue, Satoshi, Akinobu Ota, Masayuki Komura, et al.. (2021). PBK expression predicts favorable survival in colorectal cancer patients. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(2). 277–284. 17 indexed citations
7.
Kimura, Masahiro, et al.. (2020). Sporadic neurofibroma of transverse colon in a patient without neurofibromatosis type 1: A case report. International Journal of Surgery Case Reports. 71. 19–22. 1 indexed citations
8.
Ota, Akinobu, Ichiro Hanamura, Sivasundaram Karnan, et al.. (2020). Novel Interleukin-6 Inducible Gene PDZ-Binding Kinase Promotes Tumor Growth of Multiple Myeloma Cells. Journal of Interferon & Cytokine Research. 40(8). 389–405. 10 indexed citations
9.
Yamada, Hiroshi, Masahiko Yoneda, Shingo Inaguma, et al.. (2017). A Rho-Associated Kinase Inhibitor Protects Permeability in a Cell Culture Model of Ocular Disease, and Reduces Aqueous Flare in Anterior Uveitis. Journal of Ocular Pharmacology and Therapeutics. 33(3). 176–185. 11 indexed citations
10.
Inaguma, Shingo, Jerzy Lasota, Zengfeng Wang, et al.. (2017). Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma. Human Pathology. 71. 1–7. 43 indexed citations
11.
Inaguma, Shingo, Jerzy Lasota, Zengfeng Wang, et al.. (2016). Clinicopathologic profile, immunophenotype, and genotype of CD274 (PD-L1)-positive colorectal carcinomas. Modern Pathology. 30(2). 278–285. 70 indexed citations
12.
Inaguma, Shingo, Mitsuyoshi Hashimoto, Hideki Murakami, et al.. (2013). GLI1 Interferes with the DNA Mismatch Repair System in Pancreatic Cancer through BHLHE41-Mediated Suppression of MLH1. Cancer Research. 73(24). 7313–7323. 45 indexed citations
13.
Yamada, Hiroshi, Masahiko Yoneda, Shingo Inaguma, et al.. (2013). Infliximab counteracts tumor necrosis factor-α-enhanced induction of matrix metalloproteinases that degrade claudin and occludin in non-pigmented ciliary epithelium. Biochemical Pharmacology. 85(12). 1770–1782. 20 indexed citations
14.
Inaguma, Shingo, Kenji Kasai, & Hiroshi Ikeda. (2010). GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin. Oncogene. 30(6). 714–723. 89 indexed citations
15.
Kasai, Kenji, Shingo Inaguma, Akiko Yoneyama, Kazuhiro Yoshikawa, & Hiroshi Ikeda. (2008). SCL/TAL1 Interrupting Locus Derepresses GLI1 from the Negative Control of Suppressor-of-Fused in Pancreatic Cancer Cell. Cancer Research. 68(19). 7723–7729. 61 indexed citations
16.
Suzuki, Shugo, et al.. (2005). Differences between latent and clinical prostate carcinomas: Lower cell proliferation activity in latent cases. The Prostate. 66(2). 211–217. 9 indexed citations
17.
Cho, Young‐Man, Satoru Takahashi, Makoto Asamoto, et al.. (2003). Age‐dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: Lack of influence of carcinogen or testosterone treatment. Cancer Science. 94(2). 153–157. 24 indexed citations
18.
Suzuki, Shugo, Satoru Takahashi, Makoto Asamoto, et al.. (2002). Lack of modification of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced hepatocarcinogenesis in rats by fenbendazole – a CYP1A2 inducer. Cancer Letters. 185(1). 39–45. 9 indexed citations
19.
Takahashi, Satoru, Shugo Suzuki, Shingo Inaguma, et al.. (2002). Down‐regulation of human X‐box binding protein 1 (hXBP‐1) expression correlates with tumor progression in human prostate cancers. The Prostate. 50(3). 154–161. 18 indexed citations
20.
Takahashi, Satoru, Shingo Inaguma, Young‐Man Cho, et al.. (2002). DNA methylation in the androgen receptor gene promoter region in rat prostate cancers. The Prostate. 52(1). 82–88. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026